Purchase Order 75N98026P01201

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $7,072.75 on July 2, 2018, with an ultimate completion date of August 2, 2018. The order is a firm fixed-price acquisition with no set-aside designation. Place of performance is Bethesda, Maryland. The procurement is for coherent laser group equipment and services [18-046094], typical of the vendor's federal portfolio of precision laser systems and related instrumentation for scientific research applications.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $133,380.00 on September 28, 2017, with an ultimate completion date of November 16, 2017. The order is firm fixed-price with no small business set-aside. Performance takes place in Santa Clara, California. The source does not specify the laser systems or equipment being purchased.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. on December 18, 2017, with a ceiling value of $5,566.05 and an ultimate completion date of December 28, 2018. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $8,800.00 on January 18, 2018, with completion scheduled for February 11, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

The National Cancer Institute issued a purchase order to Coherent Inc. on June 30, 2021, valued at $14,751.77, for maintenance agreement services with an ultimate completion date of July 24, 2022. The order represents a firm fixed-price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of fund availability. Performance occurs in Bethesda, Maryland. No small business...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $21,636 firm fixed price purchase order to Coherent NA, Inc. for a service agreement covering the Chameleon Vision II and Chameleon MPX X laser system. Coherent NA, Inc. is a subsidiary of Coherent Inc. and will perform the work at its Rockville, Maryland facility located at 20852. The period of performance is one year, running from July 25, 2023 through July 24, 2024. No additional...

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $19,190 on July 25, 2018, for a maintenance agreement on a Coherent laser group system. Performance is located in Santa Clara, California, with an ultimate completion date of July 24, 2019. The order is firm fixed-price; no set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Coherent Inc. for $19,669.50 on July 23, 2019. The service agreement, priced on a firm fixed-price basis, calls for ultimate completion by July 24, 2020. Work is performed in Bethesda, Maryland. The source does not specify the nature of the goods or services procured.</p>

<p>The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Coherent Inc. for $22,837.30 on March 13, 2018, covering three coherent lasers: an OBIS 405NM LX 100MW laser, an OBIS 488NM LS 150MW laser, and an OBIS 561NM LS 150MW laser. Performance occurs at Bethesda, Maryland, with completion required by April 30, 2018. The order carries firm fixed pricing and uses no small business set-aside.</p>

<p>The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Coherent Inc. for a Coherent 488 nm laser and 561 nm OBIS laser, valued at $15,440.00, with an award date of July 17, 2017. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is October 17, 2017.</p>